Quantcast
Last updated on April 20, 2014 at 13:20 EDT

Latest Heart failure Stories

2014-01-14 16:26:14

Fourth Quarter 2013 Revenues Approximately $53 Million; up 62% from Q4 in 2012; 2013 Preliminary Revenues Approximately $208 Million; 87% increase from 2012 FRAMINGHAM, Mass., Jan. 14, 2014 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that it expects revenues for the fourth quarter of 2013 will be...

2014-01-09 11:46:02

22 years of data suggest need for new heart-size matching strategy to improve outcomes Current protocols for matching donor hearts to recipients foster sex mismatching and heart size disparities, according to a first-of-its kind analysis by physicians at the University of Maryland School of Medicine. Matching by donor heart size may provide better outcomes for recipients, who already face a scarcity of resources as they await a transplant. The analysis of 22 years of adult heart...

2014-01-09 08:29:26

MONT-SAINT-GUIBERT, Belgium, January 9, 2014 /PRNewswire/ -- Cardio3 BioSciences (C3BS) (NYSE Euronext Brussels and Paris: CARD), a leader in the discovery and development of regenerative, protective and reconstructive therapies for the treatment of cardiac diseases, announces today that the U.S. Food and Drug Administration (FDA) has authorized the Company's Investigational New Drug (IND) application for clinical testing of the Company's proprietary regenerative medicine...

2014-01-07 23:23:52

Doctors at one of the nation’s top cancer centers have recently published the case of a mesothelioma patient who developed heart failure after lung-removal surgery. Raleigh, NC (PRWEB) January 07, 2014 Surviving Mesothelioma is reporting on a recently-published case study of a mesothelioma patient suffering from heart failure in the wake of extrapleural pneumonectomy (EPP). During EPP, doctors remove not only the mesothelioma tumor, but also the entire pleural lining, all or part of the...

2014-01-07 23:22:07

The recognition marks the third year in a row that St. Elizabeth Health Center has been recognized with a Get With the Guidelines® gold quality achievement award. Youngstown, Ohio (PRWEB) January 07, 2014 St. Elizabeth Health Center has received the Get With the Guidelines® – Heart Failure Gold Quality Achievement Award from the American Heart Association. This award recognizes St. Elizabeth for achieving an exceptional goal of treating heart failure patients according to the...

2014-01-07 12:28:30

Single Digits Spell Danger: Higher Rate of Heart Attack, Stroke, Heart Failure - Assoc. Releases Quick Tips to Avoid Heart Health Risks NEW YORK, Jan. 7, 2014 /PRNewswire-USNewswire/ -- The cold spell sweeping New York and the nation carries a fatal threat for the elderly, warns AARP of New York State. Today, the Association is releasing tips to help people avoid the increased risk of heart attack, stroke, heart failure and other cardiovascular diseases, whose incident rates soar when the...

2014-01-07 08:29:55

3 Years of Rapid Growth Sets Pace to Surpass 200 Implants in 2014 TUCSON, Ariz., Jan. 7, 2014 /PRNewswire/ -- With 161 SynCardia temporary Total Artificial Hearts implanted in 2013, nearly double the 81 implants performed in 2011, SynCardia Systems, Inc. is on track to exceed 200 implants of the Total Artificial Heart in 2014, the company announced today. (Photo: http://photos.prnewswire.com/prnh/20140107/LA41597) "We expect demand to continue to accelerate this year," says Michael P....

2014-01-07 08:29:32

Health Economic Analysis Published in the Journal of Hypertension MINNEAPOLIS, Jan. 7, 2014 /PRNewswire/ -- CVRx, Inc., a privately held medical device company, today announced findings from a health-economic analysis published in the Journal of Hypertension that indicates Barostim Therapy is a cost-effective treatment option for patients with drug resistant hypertension. Based on blood pressure reductions attained with Barostim therapy, the Markov model used for this analysis projected that...

2014-01-06 08:26:19

- Statistically significant improvement in key parameters of heart function, including left ventricular ejection fraction and cardiac output SAN DIEGO, Jan. 6, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX) today announced that, in a placebo-controlled, nonclinical model of chronic heart failure, MST-188 demonstrated a statistically significant improvement in numerous parameters of heart function, including left ventricular ejection fraction and end-systolic volume,...

French Patient Recovering Well After Receiving First Long-Term Artificial Heart
2013-12-30 07:02:21

redOrbit Staff & Wire Reports – Your Universe Online Less than two weeks after becoming the first person ever to receive a long-term artificial heart, a 75-year-old Frenchman is said to be recovering well, various media outlets reported on Sunday. Professor Daniel Duveau, one of the surgeons who performed the December 18 operation at the Georges Pompidou European Hospital in Paris, said that the man was “awake, feeding himself and talking with his family,” according to Reuters...


Latest Heart failure Reference Libraries

Circulation (journal)
2012-06-04 14:21:01

Circulation is a scientific journal published by Lippincott Williams & Wilkins on behalf of the American Heart Association. In 2008 the journal added six subspecialty publications: Circulation: Arrhythmia and Electrophysiology, Circulation: Heart Failure, Circulation: Cardiovascular Imaging, Circulation: Cardiovascular Interventions, Circulation: Cardiovascular Quality and Outcomes, and Circulation: Cardiovascular Genetics. Circulation publishes articles related to research in and the...

More Articles (1 articles) »